Apr 28, 2026 04:42PM
Apr 28, 2026 04:01PM
Mar 10, 2026 08:44AM
Mar 10, 2026 08:32AM
Mar 9, 2026 04:19PM
Mar 9, 2026 04:01PM
Nov 5, 2025 04:03PM Design Therapeutics plans DM1 patient dosing for first half 2026
Nov 5, 2025 04:01PM
Aug 7, 2025 04:01PM
May 7, 2025 06:01PM
May 7, 2025 04:01PM
Mar 10, 2025 07:08AM
Mar 10, 2025 07:07AM
Mar 10, 2025 07:07AM Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial Results
Nov 8, 2024 04:28PM
Nov 7, 2024 04:01PM
Aug 5, 2024 03:59PM
Aug 5, 2024 08:00AM
May 8, 2024 04:05PM
Mar 19, 2024 04:34PM
Mar 19, 2024 04:02PM Design Therapeutics Inc. (DSGN) Outlines Progress Across GeneTAC Platform, Reports Q4
Mar 19, 2024 04:01PM
Mar 12, 2024 06:30AM
Nov 14, 2023 03:52AM
Nov 13, 2023 04:05PM
Aug 15, 2023 06:44AM
Aug 14, 2023 04:05PM
May 9, 2023 04:05PM Design Therapeutics Provides Pipeline Updates and Reports First Quarter 2023 Financial Results
Mar 14, 2023 04:05PM
Mar 14, 2023 04:05PM
Nov 3, 2022 04:05PM
Nov 3, 2022 04:05PM
Aug 8, 2022 04:05PM
Aug 8, 2022 04:05PM
May 9, 2022 04:05PM Design Therapeutics Highlights Clinical and Research Progress and Reports First Quarter 2022 Financial Results
May 9, 2022 04:05PM
Mar 10, 2022 04:02PM
Mar 10, 2022 04:02PM
Nov 9, 2021 04:05PM
Nov 9, 2021 04:05PM
Aug 9, 2021 04:05PM
Aug 9, 2021 04:05PM Design Therapeutics Reports GeneTAC™ Portfolio Progress and Second Quarter 2021 Results
May 10, 2021 04:05PM
May 10, 2021 04:05PM

1,199,636 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All